Srivastava Sapna

Srivastava Sapna is listed in filings as Director at Tourmaline Bio, Inc.. This profile follows SEC Form 4 activity through Oct 28, 2025, including 12 public disclosures. Recent filings connect the profile to Tourmaline Bio, Inc. (TRML), Alumis Inc. Common Stock (ALMS), Aura Biosciences, Inc. (AURA), and Innoviva, Inc. - Common Stock (INVA). The current snapshot covers public activity from Jun 20, 2024 to Oct 28, 2025. Reported amounts are shown as $314.7K to $139.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.